Technology transfer of innovator drug, Minocycline Hydrochloride Capsules (Meiman), is approved for manufacturing, making Hanhui the first company in China to realize the localization of innovator drug.
Irbesartan Tablets, Rosuvastatin Calcium Tablets and Meropenem for Injection are the first three products in China passing the consistency evaluation; Minocycline hydrochloride capsules has been listed as Reference Listed Drug; and Hanhui is the first enterprise to pass the consistency evaluation of simvastatin tablets and fludarabine phosphate for injection.
Manufacturing technology transfer of Pfizer innovator Minocycline Hydrochloride Capsules (Meiman), Amlodipine Besylate and Atorvastatin Calcium Tablets (DuoDaYi), and Piperacillin Sodium and Tazobactam Sodium for Injection (Tazocin) have successfully completed to achieve the localization of high-quality innovator. Amlodipine Besylate and Atorvastatin Calcium Tablets (DuoDaYi) and Piperacillin Sodium and Tazobactam Sodium for Injection (Tazocin) have been included in the Approved Drug Catalog.
Technology transfer of innovator drug, Minocycline Hydrochloride Capsules (Meiman), is approved for manufacturing, making Hanhui the first company in China to realize the localization of innovator drug.
Irbesartan Tablets, Rosuvastatin Calcium Tablets and Meropenem for Injection are the first three products in China passing the consistency evaluation; Minocycline hydrochloride capsules has been listed as Reference Listed Drug; and Hanhui is the first enterprise to pass the consistency evaluation of simvastatin tablets and fludarabine phosphate for injection.
Manufacturing technology transfer of Pfizer innovator Minocycline Hydrochloride Capsules (Meiman), Amlodipine Besylate and Atorvastatin Calcium Tablets (DuoDaYi), and Piperacillin Sodium and Tazobactam Sodium for Injection (Tazocin) have successfully completed to achieve the localization of high-quality innovator. Amlodipine Besylate and Atorvastatin Calcium Tablets (DuoDaYi) and Piperacillin Sodium and Tazobactam Sodium for Injection (Tazocin) have been included in the Approved Drug Catalog.